CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report)‘s stock had its “market outperform” rating restated by research analysts at Citizens Jmp in a research note issued to investors on Tuesday,Benzinga reports. They currently have a $86.00 price objective on the stock. Citizens Jmp’s price objective points to a potential upside of 48.51% from the stock’s current […]

Core Scientific (NASDAQ:CORZ – Get Free Report) was upgraded by research analysts at Citizens Jmp from a “market perform” rating to a “market outperform” rating in a report issued on Thursday,Benzinga reports. The brokerage presently has a $30.00 target price on the stock. Citizens Jmp’s price target would indicate a potential upside of 121.08% from […]

Citizens Jmp restated their market outperform rating on shares of Braze (NASDAQ:BRZE – Free Report) in a research note published on Wednesday morning,Benzinga reports. They currently have a $68.00 price target on the stock. A number of other brokerages have also weighed in on BRZE. Mizuho raised their price target on shares of Braze from […]

AeroVironment (NASDAQ:AVAV – Get Free Report)‘s stock had its “market outperform” rating reissued by equities researchers at Citizens Jmp in a report issued on Wednesday,Benzinga reports. They currently have a $400.00 price objective on the aerospace company’s stock. Citizens Jmp’s price target would suggest a potential upside of 42.14% from the stock’s previous close. Other […]